E. Roilides et al., INCREASED SERUM CONCENTRATIONS OF INTERLEUKIN-10 IN PATIENTS WITH HEPATOSPLENIC CANDIDIASIS, The Journal of infectious diseases, 178(2), 1998, pp. 589-592
Hepatosplenic candidiasis (HSC) becomes clinically overt in cancer pat
ients upon recovery from neutropenia, HSC may be a consequence of a Th
1-Th2 imbalance, characterized by increased serum levels of one or mor
e cytokines. Serum levels of two immunosuppressive cytokines, markers
of the Th2 pathway, interleukin (IL)-4 and IL-10 were measured by ELIS
A in 10 patients with HSC (22 samples) and compared with 19 healthy bl
ood donors, 13 patients with cancer but no infection (23 samples), and
11 patients with cancer and various bacterial infections (17 samples)
. IL-4 was undetectable in all controls and patients. By contrast, lev
els of IL-10 were increased in HSC patients compared with levels in he
althy donors and cancer patients without infection (P < .001) or with
bacterial infections (P < .01). These findings indicate that IL-10 but
not IL-4 is increased in patients with HSC and suggest that IL-10 pla
ys a role in the pathogenesis of this infection.